Eudaimonia Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,576
Closed -$213K 256
2023
Q3
$213K Sell
1,576
-14
-0.9% -$1.91K 0.05% 294
2023
Q2
$228K Sell
1,590
-169
-10% -$24.9K 0.05% 299
2023
Q1
$244K Buy
1,759
+116
+7% +$15.6K 0.06% 290
2022
Q4
$223K Buy
+1,643
New +$206K 0.05% 305
2022
Q3
Sell
-7,418
Closed -$980K 344
2022
Q2
$980K Buy
7,418
+664
+10% +$87.1K 0.18% 135
2022
Q1
$896K Buy
+6,754
New +$810K 0.15% 164
2021
Q3
$867K Buy
7,219
+470
+7% +$54.7K 0.16% 161
2021
Q2
$808K Sell
6,749
-588
-8% -$64.5K 0.15% 165
2021
Q1
$729K Sell
7,337
-153
-2% -$15.4K 0.15% 154
2020
Q4
$749K Buy
7,490
+477
+7% +$50.5K 0.17% 140
2020
Q3
$769K Buy
7,013
+2,420
+53% +$269K 0.2% 121
2020
Q2
$486K Buy
4,593
+656
+17% +$67.8K 0.18% 129
2020
Q1
$352K Buy
3,937
+2,500
+174% +$235K 0.15% 157
2019
Q4
$143K Buy
+1,437
New +$135K 0.06% 291

Other funds holding AZN